ART
Abbildung 1: Indications for ART-related diagnosis according to the kind of sperm retrieval 1998–2008 (302,413 ART cycles).

ART
Abbildung 2: Increase in annual numbers for ART cycles with cryopreserved ejaculated sperm or fresh or frozen testicular sperm (TESE/“cryo“-TESE) 1998–2008 (total 25,740 ART cycles).

ART
Abbildung 3: Means (± 95 %-confidence interval [CI]) for fertilization rate, pregnancy rate, birth and miscarriage rate and singleton pregnancy rate for ejaculated, cryopreserved or testicular sperm in percent (%), 293,312 ART cycles 1998–2008, lost for follow-up 13.7 %.

ART
Abbildung 4: Annual pregnancy rates (%) for cryopreserved ejaculated sperm and fresh or frozen testicular sperm (means ± 95 %-CI), p < 0.05 in 2002; 1998–2008 (total 25,740 ART cycles).

ART
Abbildung 5: Annual development of ART cycles in Germany 1998–2008 (n = 498,784). IVF/ICSI cycles are fresh cycles in which oocyctes are divided for both IVF and ICSI treatment.

IVF -ICSI
Abbildung 6: Percentage of fertilisation failure in IVF (line with filled circle) or ICSI cycles (line with filled quad) plotted against the number of oocytes available for fertilisation (1999–2001).

IVF - ICSI
Abbildung 7: Percentage of IVF (line with filled circle) and ICSI (line with filled quad) cycles (n = 488,174) performed plotted against the number of oocytes available for fertilisation (1998–2008).

IVF - ICSI
Abbildung 8: Percentage of IVF (line with filled circle) and ICSI (line with filled quad) cycles (n = 488,174) performed plotted against the female age (1998–2008), means for percentage of IVF and ICSI treatments are marked by solid lines.

ICSI
Abbildung 9: Percentage of ICSI cycles in private fertility centers (dashed line with triangle) and public general or university hospitals (solid line with quad) (1998–2008).

IVF - ICSI
Abbildung 10: Means (± 95 %-CI) for number of oocytes retrieved (n = 4,610,133) in IVF (line with circle) or ICSI (line with quad) cycles (1998–2008).

IVF - ICSI
Abbildung 11: Mean pregnancy rates (± 95 %-CI) for stimulated IVF or ICSI cycles with recombinant FSH (rFSH) and urinary menotropin (hMG), 280,394 prospective cycles, D.I.R, 1998–2008.

ART
Abbildung 12: Mean percentage rates (± 95 %-CI) of rFSH and hMG application for IVF or ICSI treatment in relation to changes in the reimbursement of ART cycles by the public health insurance, 280,394 prospective cycles, D.I.R 1998–2008.

IVF - ICSI
Abbildung 13: Mean percentage rates (± 95 %-CI) of rFSH or hMG stimulated IVF or ICSI cycles leading to oocyte retrieval in women > 34 years, 280,394 prospective cycles, D.I.R 1998–2008.

IVF - ICSI
Abbildung 14